Cited by 175Hyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes Management and ResearchIntensive Care Unit Cognitive Disorders

The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.

Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults

Open access

Krinsley, James S, Preiser, Jean-Charles·2015·Critical Care

DOI 10.1186/s13054-015-0908-7PMC PMC4446958

Open this paper in CoChat — free account Open PDF

Abstract

Introduction: Hyperglycemia, hypoglycemia and increased glucose variability are independently associated with increased risk of death in critically ill adults. The relationship between time in targeted blood glucose range (TIR) and mortality is not well described and may be a factor that has confounded the results of the major interventional trials of intensive insulin therapy. Methods: We conducted a retrospective analysis of prospectively collected data involving 3,297 patients with intensive care unit (ICU) lengths of stay (LOS) of ≥1.0 day who were admitted between 1 January 2009 and 31 December 2013 to a single mixed medical-surgical ICU. We investigated the relationship between TIR 70 to 140 mg/dl with mortality and compared outcomes of non-diabetics (NON) and individuals with diabetes mellitus (DM), including stratifying by TIR above (TIR-hi) and below (TIR-lo) the median value for the NON and DM groups. Results: There were 85,799 blood glucose (BG) values for the NON group and 32,651 for the DM group, and we found that 75.5% and 54.8%, respectively, were between 70 and 140 (P <0.0001). The median (interquartile range) TIR (%) values for the NON and DM groups were 80.6% (61.4% to 94.0%) and 55.0% (35.5% to 71.1%), respectively (P <0.0001). For the NON group, mortality was 8.47% and 15.71% for TIR-hi and TIR-lo, respectively (P <0.0001). For the DM group, mortality was 16.09% and 14.44% for TIR-hi and TIR-lo, respectively (P = NS). We observed similar relationships for the NON group when we stratified by ICU LOS or severity of illness, especially in the most severely ill patients. There was a cumulative interaction of indices of hypoglycemia, hyperglycemia or glucose variability with TIR. Multivariable analysis demonstrated, for the NON group, that TIR-hi was independently associated with increased survival (P =0.0019). For the NON group, the observed-to-expected mortality ratios for TIR-hi and TIR-lo, based on Acute Physiology and Chronic Health Evaluation IV methodology, were 0.53 and 0.78, respectively. In contrast, among those in the DM group, there was no clear relationship between TIR 70 to 140 mg/dl and survival. Conclusions: Independently of ICU LOS and severity of illness, TIR 70 to 140 mg/dl >80% is strongly associated with survival in critically ill patients without diabetes. These findings have implications for the design of clinical protocols for glycemic control in critically ill patients as well for the design of future interventional trials of intensive insulin therapy.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13054-015-0908-7

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Distribution of percentages time in targeted blood glucose range for patients without or with diabetes. DM, Diabetes mellitus group; NON, Patients without diabetes mellitus; TIR, Time in targeted blood glucose range.CC BY · PubMed Central

Figure 2 Relationship of time in range to mortality, stratified by intensive care unit length of stay, in the group of patients without diabetes. ICU LOS, Intensive care unit length of stay; TIR-hi, Time in targeted blood glucose range above median value for non-diabetic and diabetes mellitus groups; TIR-lo, Time in targeted blood glucose range below median value for non-diabetic and diabetes mellitus groups.CC BY · PubMed Central

Figure 3 Relationship of time in range to mortality, stratified by Acute Physiology Score, in the group of patients without diabetes. APS, Acute Physiology Score component of the Acute Physiology and Chronic Health Evaluation IV severity scoring system; TIR-hi, Time in targeted blood glucose range above median value for non-diabetic and diabetes mellitus groups; TIR-lo, Time in targeted blood glucose range below median value for non-diabetic and diabetes mellitus groups.CC BY · PubMed Central

Figure 4 Observed-to-expected mortality ratio for of time above and below targeted blood glucose range in the group of patients without diabetes. TIR-hi, Time in targeted blood glucose range above median value for non-diabetic and diabetes mellitus groups; TIR-lo, Time in targeted blood glucose range below median value for non-diabetic and diabetes mellitus groups.CC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Comment on: American Diabetes Association. Standards of Medical Care in Diabetes—2011. Diabetes Care 2011;34(Suppl. 1):S11–S61
Basevi, V., Mario, S. D., Morciano, C., Nonino, F., & Magrini, N. (2011) · Diabetes Care · doi:10.2337/dc11-0174 · Cited by 3,058
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
Acute Physiology and Chronic Health Evaluation (APACHE) IV: Hospital mortality assessment for today’s critically ill patients*
Zimmerman, J. E., Kramer, A. A., McNair, D. S., & Malila, F. M. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000215112.84523.f0 · Cited by 1,764
Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients
Krinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165
Self-citation
Hypoglycemia and risk of death in critically ill patients
The NICE-SUGAR Study Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204942 · Cited by 1,009
A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study
Preiser, J.-C., Devos, P., Ruiz-Santana, S., Mélot, C., Annane, D., Groeneveld, J., Iapichino, G., Leverve, X., Nitenberg, G., Singer, P., et al. (2009) · Intensive Care Medicine · doi:10.1007/s00134-009-1585-2 · Cited by 911
Self-citation

Show all 41 references

Sorted by citations

Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
ESPEN guideline on clinical nutrition in the intensive care unit.
Singer, P., Blaser, A. R., Berger, M. M., Alhazzani, W., Calder, P. C., Casaer, M. P., Hiesmayr, M., Mayer, K., Montejo, J. C., Pichard, C., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.037 · Cited by 2,904
Self-citation
Next-generation, personalised, model-based critical care medicine: a state-of-the art review of in silico virtual patient models, methods, and cohorts, and how to validation them
Chase, J. G., Preiser, J., Dickson, J. L., Pironet, A., Chiew, Y. S., Pretty, C. G., Shaw, G. M., Benyó, B. I., Möeller, K., Safaei, S., et al. (2018) · BioMedical Engineering OnLine · doi:10.1186/s12938-018-0455-y · Cited by 191
Self-citation
Monitoring nutrition in the ICU
Berger, M. M., Reintam-Blaser, A., Calder, P. C., Casaer, M., Hiesmayr, M. J., Mayer, K., Montejo, J. C., Pichard, C., Preiser, J.-C., van Zanten, A. R. H., et al. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.07.009 · Cited by 171
Self-citation
Continuous glucose monitoring in the ICU: clinical considerations and consensus
Krinsley, J. S., Chase, J. G., Gunst, J., Mårtensson, J., Schultz, M. J., Taccone, F. S., Wernerman, J., Bohé, J., Block, C. E. M. D., Desaive, T., et al. (2017) · Critical Care · doi:10.1186/s13054-017-1784-0 · Cited by 150
Self-citation
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes
Gabbay, M. A. L., Rodacki, M., Calliari, L. E., Vianna, A. G. D., Krakauer, M., Pinto, M. S., Reis, J. S., Puñales, M. K., Miranda, L. G., Ramalho, A. C., et al. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-00529-z · Cited by 143
Safety, efficacy and clinical generalization of the STAR protocol: a retrospective analysis
Stewart, K. W., Pretty, C. G., Tomlinson, H., Thomas, F., Homlok, J., Némedi, N. S., Illyés, A., Shaw, G. M., Benyó, B. I., & Chase, J. G. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0125-9 · Cited by 123
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00685-0 · Cited by 128
Type 2 diabetes mellitus and sepsis: state of the art, certainties and missing evidence
Costantini, E., Carlin, M., Porta, M., & Brizzi, M. F. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01728-4 · Cited by 114
Variability in HbA1c , blood pressure, lipid parameters and serum uric acid, and risk of development of chronic kidney disease in type 2 diabetes
Ceriello, A., Cosmo, S. D., Rossi, M. C., Lucisano, G., Genovese, S., Pontremoli, R., Fioretto, P., Giorda, C. B., Pacilli, A., Viazzi, F. C., et al. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12976 · Cited by 100
Higher glycemic variability within the first day of ICU admission is associated with increased 30-day mortality in ICU patients with sepsis
Chao, W.-C., Tseng, C., Wu, C., Shih, S., Yi, C.-Y., & Chan, M.-C. (2020) · Annals of Intensive Care · doi:10.1186/s13613-020-0635-3 · Cited by 98
COVID-19 infection in Italian people with diabetes: Lessons learned for our future (an experience to be used)
Gentile, S., Strollo, F., & Ceriello, A. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108137 · Cited by 98
Digital health application integrating wearable data and behavioral patterns improves metabolic health
Zahedani, A. D., McLaughlin, T., Veluvali, A., Aghaeepour, N., Hosseinian, A., Agarwal, S., Ruan, J., Tripathi, S., Woodward, M., Hashemi, N., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00956-y · Cited by 96
“The group as a whole ( n = 1066) demonstrated relatively high baseline TIR, measuring 82% among T2D (70 – 180 mg/dL range) and 91% among those with prediabetes and healthy nondiabetics (70 – 140 mg/dL range), consistent with prior studies 24,25,39 .”
The Interaction of Acute and Chronic Glycemia on the Relationship of Hyperglycemia, Hypoglycemia, and Glucose Variability to Mortality in the Critically Ill*
Krinsley, J. S., Rule, P., Pappy, L., Ahmed, A., Huley-Rodrigues, C., Prevedello, D., & Preiser, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004599 · Cited by 90
Self-citation
Continuous glucose monitoring in neonates: a review
McKinlay, C. J. D., Chase, J. G., Dickson, J. L., Harris, D. L., Alsweiler, J. M., & Harding, J. E. (2017) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-017-0055-z · Cited by 87
Increased Postoperative Glucose Variability Is Associated with Adverse Outcomes Following Total Joint Arthroplasty
Shohat, N., Restrepo, C., Allierezaie, A., Tarabichi, M., Goel, R. K., & Parvizi, J. (2018) · Journal of Bone and Joint Surgery · doi:10.2106/jbjs.17.00798 · Cited by 83
Glucose Control in the ICU
Preiser, J., Chase, J. G., Hovorka, R., Joseph, J. I., Krinsley, J. S., Block, C. E. M. D., Desaive, T., Foubert, L. A., Kalfon, P., Pielmeier, U., et al. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816648713 · Cited by 82
Self-citation
Generalisability of a Virtual Trials Method for Glycaemic Control in Intensive Care
Dickson, J. L., Stewart, K. W., Pretty, C. G., Flechet, M., Desaive, T., Penning, S., Lambermont, B. C., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2686432 · Cited by 73
Percentage of Time in Range 70 to 139 mg/dL Is Associated With Reduced Mortality Among Critically Ill Patients Receiving IV Insulin Infusion
Lanspa, M. J., Krinsley, J. S., Hersh, A. M., Wilson, E. L., Holmen, J. R., Orme, J. F., Morris, A. H., & Hirshberg, E. L. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.05.016 · Cited by 72
Self-citation
Untangling glycaemia and mortality in critical care
Uyttendaele, V., Dickson, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2017) · Critical Care · doi:10.1186/s13054-017-1725-y · Cited by 71
Safety and Efficacy of Personalized Glycemic Control in Critically ill Patients: A 2-Year Before and After Interventional Trial
Krinsley, J. S., Preiser, J., & Hirsch, I. B. (2016) · Endocrine Practice · doi:10.4158/ep161532.or · Cited by 66
Self-citation
Expert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 67
A systematic scoping review on the consequences of stress-related hyperglycaemia
Olariu, E., Pooley, N., Danel, A., Miret, M., & Preiser, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194952 · Cited by 64
Self-citation
Advances in Medical Nutrition Therapy: Parenteral Nutrition
Itzhaki, M. H., & Singer, P. (2020) · Nutrients · doi:10.3390/nu12030717 · Cited by 66
Glucose management in critically ill adults and children
Mesotten, D., Preiser, J., & Kosiborod, M. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00223-5 · Cited by 61
Self-citation
Liberal Glucose Control in ICU Patients With Diabetes: A Before-and-After Study*
Luethi, N., Cioccari, L., Biesenbach, P., Lucchetta, L., Kagaya, H., Morgan, R., Muzio, F. D., Presello, B., Gaafar, D., Hay, A., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000003087 · Cited by 60
Relationship between Measures of Neonatal Glycemia, Neonatal Illness, and 2-Year Outcomes in Very Preterm Infants
Tottman, A. C., Alsweiler, J. M., Bloomfield, F. H., Pan, M., & Harding, J. E. (2017) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2017.05.052 · Cited by 56
Clinical Management of Diabetes Mellitus in the Era of COVID-19: Practical Issues, Peculiarities and Concerns
Koliaki, C. C., Tentolouris, A., Eleftheriadou, I., Melidonis, A. J., Dimitriadis, G., & Tentolouris, N. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9072288 · Cited by 56
Improving glycemic control in critically ill patients: personalized care to mimic the endocrine pancreas
Chase, J. G., Desaive, T., Bohé, J., Cnop, M., Block, C. E. M. D., Gunst, J., Hovorka, R., Kalfon, P., Krinsley, J. S., Renard, É., et al. (2018) · Critical Care · doi:10.1186/s13054-018-2110-1 · Cited by 54
Self-citation
Impact of blood glucose abnormalities on outcomes and disease severity in patients with severe sepsis: An analysis from a multicenter, prospective survey of severe sepsis
Kushimoto, S., Abe, T., Ogura, H., Shiraishi, A., Saitoh, D., Fujishima, S., Mayumi, T., Hifumi, T., Shiino, Y., Nakada, T., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229919 · Cited by 52
Randomized Evaluation of Glycemic Control in the Medical Intensive Care Unit Using Real-Time Continuous Glucose Monitoring (REGIMEN Trial)
Block, C. E. M. D., Gios, J., Verheyen, N., Manuel‐y‐Keenoy, B., Rogiers, P., Jorens, P. G., Scuffi, C., & Gaal, L. F. V. (2015) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2015.0151 · Cited by 50
Update on glucose in critical care
Lheureux, O., Prevedello, D., & Preiser, J. (2018) · Nutrition · doi:10.1016/j.nut.2018.06.027 · Cited by 49
Self-citation
Glycemic control in the intensive care unit: A control systems perspective
Chase, J. G., Benyó, B. I., & Desaive, T. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.03.007 · Cited by 46
Glycemic control in the critically ill: Less is more
Alhatemi, G., Aldiwani, H., Alhatemi, R., Hussein, M., Mahdai, S., & Seyoum, B. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.20171 · Cited by 50
Exogenous Ketones Lower Blood Glucose Level in Rested and Exercised Rodent Models
Ari, C., Murdun, C., Koutnik, A. P., Goldhagen, C. R., Rogers, C. Q., Park, C. R., Bharwani, S., Diamond, D. M., Kindy, M. S., D’Agostino, D. P., et al. (2019) · Nutrients · doi:10.3390/nu11102330 · Cited by 43
Glycemic control in the critically ill: What have we learned since NICE-SUGAR?
Krinsley, J. S. (2015) · Hospital Practice · doi:10.1080/21548331.2015.1066227 · Cited by 39
Self-citation
Is it time to abandon glucose control in critically ill adult patients?
Krinsley, J. S., & Preiser, J. (2019) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000621 · Cited by 37
Self-citation
Blood Glucose Levels and Mortality in Patients With Sepsis: Dose–Response Analysis of Observational Studies
Wang, W., Chen, W., Liu, Y., Li, L., Li, S., Tan, J., & Sun, X. (2019) · Journal of Intensive Care Medicine · doi:10.1177/0885066619889322 · Cited by 36
The effect of a low carbohydrate formula on glycaemia in critically ill enterally-fed adult patients with hyperglycaemia: A blinded randomised feasibility trial
Doola, R., Deane, A. M., Tolcher, D. M., Presneill, J., Barrett, H. L., Forbes, J. M., Todd, A. S., Okano, S., & Sturgess, D. J. (2019) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2019.02.013 · Cited by 36
Relative Hypoglycemia and Lower Hemoglobin A1c-Adjusted Time in Band Are Strongly Associated With Increased Mortality in Critically Ill Patients
Krinsley, J. S., Rule, P. R., Roberts, G. W., Brownlee, M., Preiser, J., Chaudry, S., Dionne, K. D., Heluey, C., Umpierrez, G. E., & Hirsch, I. B. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005490 · Cited by 33
Self-citation
Glycaemic variability and its association with enteral and parenteral nutrition in critically ill ventilated patients
Doola, R., Greer, R. M., Hurford, R., Flatley, C. J., Forbes, J. M., Todd, A. S., Joyce, C., & Sturgess, D. J. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.08.001 · Cited by 32
Dysglycemia in the critically ill patient: current evidence and future perspectives
Aramendi, I., Burghi, G., & Manzanares, W. (2017) · Revista Brasileira de Terapia Intensiva · doi:10.5935/0103-507x.20170054 · Cited by 36
Early glycemia and mortality in critically ill septic patients: Interaction with insulin-treated diabetes
Magee, F., Bailey, M., Pilcher, D. V., Mårtensson, J., & Bellomo, R. (2018) · Journal of Critical Care · doi:10.1016/j.jcrc.2018.03.012 · Cited by 31
In Silico Testing of an Artificial-Intelligence-Based Artificial Pancreas Designed for Use in the Intensive Care Unit Setting
DeJournett, L., & DeJournett, J. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816653967 · Cited by 31
3D kernel-density stochastic model for more personalized glycaemic control: development and in-silico validation
Uyttendaele, V., Knopp, J. L., Davidson, S. M., Desaive, T., Benyó, B. I., Shaw, G. M., & Chase, J. G. (2019) · BioMedical Engineering OnLine · doi:10.1186/s12938-019-0720-8 · Cited by 31
S3-Leitlinie Sepsis – Prävention, Diagnose, Therapie und Nachsorge
Deutsche Sepsis Gesellschaft e., V., Brunkhorst, F. M., Weigand, M. A., Pletz, M. W., Gastmeier, P., Lemmen, S., Meier‐Hellmann, A., Ragaller, M., Weyland, A., Marx, G., et al. (2020) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/s00063-020-00671-6 · Cited by 31
Protein glycation in diabetes mellitus
Shin, A., Connolly, S. M., & Kabytaev, K. (2023) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.11.003 · Cited by 34
A comparison of two insulin infusion protocols in the medical intensive care unit by continuous glucose monitoring
Block, C. E. M. D., Rogiers, P., Jorens, P. G., Schepens, T., Scuffi, C., & Gaal, L. F. V. (2016) · Annals of Intensive Care · doi:10.1186/s13613-016-0214-9 · Cited by 30
Time in range in relation to amputation and all‐cause mortality in hospitalised patients with diabetic foot ulcers
Xie, P., Deng, B., Zhang, X., Li, Y., Du, C., Rui, S., Deng, W., Boey, J., Armstrong, D. G., Ma, Y., et al. (2021) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3498 · Cited by 29
Continuous Glucose Monitoring Measures Can Be Used for Glycemic Control in the ICU: An In-Silico Study
Zhou, T., Dickson, J. L., Shaw, G. M., & Chase, J. G. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817738791 · Cited by 26
Glycemic targets in critically ill adults: A mini-review
See, K. C. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i10.1719 · Cited by 28
miR-1273g-3p participates in acute glucose fluctuation-induced autophagy, dysfunction, and proliferation attenuation in human umbilical vein endothelial cells
Guo, J., Sang, Y., Yin, T., Wang, B., Yang, W., Li, X., Li, H., & Kang, Y. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00444.2015 · Cited by 26
Effects of Variability in Blood Pressure, Glucose, and Cholesterol Concentrations, and Body Mass Index on End-Stage Renal Disease in the General Population of Korea
Kim, M. K., Han, K., Kim, H., Park, Y., Kwon, H., Yoon, K., & Lee, S. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050755 · Cited by 25
Is intensive insulin therapy the scapegoat for or cause of hypoglycaemia and poor outcome?
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2019) · IFAC Journal of Systems and Control · doi:10.1016/j.ifacsc.2019.100063 · Cited by 24
The Long and Winding Road Toward Personalized Glycemic Control in the Critically Ill
Krinsley, J. S. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817728299 · Cited by 23
Self-citation
Manual versus Automated moNitoring Accuracy of GlucosE II (MANAGE II)
Shinotsuka, C. R., Brasseur, A., Fagnoul, D., So, T., Vincent, J., & Preiser, J. (2016) · Critical Care · doi:10.1186/s13054-016-1547-3 · Cited by 23
Self-citation
Glucose as an additional parameter to National Early Warning Score (NEWS) in prehospital setting enhances identification of patients at risk of death: an observational cohort study
Vihonen, H., Lääperi, M., Kuisma, M., Pirneskoski, J., & Nurmi, J. O. (2020) · Emergency Medicine Journal · doi:10.1136/emermed-2018-208309 · Cited by 23
Model-based glycemic control in a Malaysian intensive care unit: performance and safety study
Abu-Samah, A., Dickson, J. L., Razak, N. N. A., Razak, A. A., Jamaludin, U. K., Suhaimi, F. M., Ralib, A. M., Nor, M. B. M., Chase, J. G., & Pretty, C. G. (2019) · Medical Devices Evidence and Research · doi:10.2147/mder.s187840 · Cited by 20
What, why and how to monitor blood glucose in critically ill patients
Juneja, D., Deepak, D., & Nasa, P. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i5.528 · Cited by 18
Threshold of hyperglycaemia associated with mortality in critically ill patients: a multicentre, prospective, observational study using continuous glucose monitoring
Wang, Y., Li, S., Lu, J., Feng, K., Huang, X., Hu, F., Sun, M., Zou, Y., Li, Y., Huang, W., et al. (2024) · Diabetologia · doi:10.1007/s00125-024-06136-1 · Cited by 19
Hyperglycemia is a predictor of prognosis in traumatic brain injury: Tertiary intensive care unit study
Bebi̇toğlu, B. T., Ekinci, O., & Berkman, Z. (2015) · Journal of Research in Medical Sciences · doi:10.4103/1735-1995.172984 · Cited by 18
Postoperative Glycemic Variability as a Predictor of Adverse Outcomes Following Lumbar Fusion
Canseco, J. A., Chang, M. P., Karamian, B. A., Nicholson, K. J., Patel, P. D., Shenoy, K., Hartman, J., Kurd, M. F., Rihn, J. A., Anderson, D. G., et al. (2021) · Spine · doi:10.1097/brs.0000000000004214 · Cited by 17
Nutrition delivery, workload and performance in a model-based ICU glycaemic control system
Stewart, K. W., Chase, J. G., Pretty, C. G., & Shaw, G. M. (2018) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2018.09.005 · Cited by 17
Glycemic Variability Is Independently Associated With Poor Prognosis in Five Pediatric ICU Centers in Southwest China
Dong, M., Liu, W., Luo, Y., Li, J., Huang, B., Zou, Y., Liu, F., zhang, G., Ju, C. A., jiang, J., et al. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.757982 · Cited by 16
Insulin sensitivity in critically ill patients: are women more insulin resistant?
Uyttendaele, V., Chase, J. G., Knopp, J. L., Gottlieb, R., Shaw, G. M., & Desaive, T. (2021) · Annals of Intensive Care · doi:10.1186/s13613-021-00807-7 · Cited by 16
Anti-inflammatory and organ protective effect of insulin in scalded MODS rats without controlling hyperglycemia
Zhu, Z., Hu, T. H., Wang, Z., Wang, J., Liu, R., Yang, Q., Zhang, X., & Xiong, Y. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.07.070 · Cited by 16
Traversing the valley of glycemic control despair
Chase, J. G., & Dickson, J. L. (2017) · Critical Care · doi:10.1186/s13054-017-1824-9 · Cited by 16
Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines
Zabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2020) · Annals of critical care · doi:10.21320/1818-474x-2020-s1-9-120 · Cited by 15
Time in blood glucose range 70 to 180 mg/dL and survival rate in critically ill patients: A retrospective cohort study
Naraba, H., Goto, T., Shirakawa, T., Sonoo, T., Kanda, N., Nakano, H., Takahashi, Y., Hashimoto, H., & Nakamura, K. (2021) · PLoS ONE · doi:10.1371/journal.pone.0252158 · Cited by 15
Autoregressive Modeling of Drift and Random Error to Characterize a Continuous Intravascular Glucose Monitoring Sensor
Zhou, T., Dickson, J. L., & Chase, J. G. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817719089 · Cited by 15
Efficacy and safety of a morning injection of insulin glargine 300 units/mL versus insulin glargine 100 units/mL in adult patients with type 1 diabetes: A multicentre, randomized controlled trial using continuous glucose monitoring
Pettus, J., Gill, J., Paranjape, S., Stewart, J. A., Malla, S., Edelman, S. V., Bergenstal, R. M., & Bode, B. W. (2019) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13751 · Cited by 15
Intensive insulin therapy increases glutathione synthesis rate in surgical ICU patients with stress hyperglycemia
Biolo, G., Massolino, B., Girolamo, F. G. D., Fiotti, N., Mearelli, F., Mazzucco, S., Bertuzzi, C. A., Lazzarini, R., Colombatti, A., & Cicco, M. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190291 · Cited by 15
Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines
Zabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2021) · Annals of critical care · doi:10.21320/1818-474x-2021-s1-9-143 · Cited by 13
Anesthesia and intensive care for patients with COVID-19. Russian Federation of anesthesiologists and reanimatologists guidelines
Zabolotskikh, I. B., Кirov, М. Y., Лебединский, К. М., Николаевич, П. Д., Avdeev, S. N., Andreenko, A. A., Arsentev, L. V., Афончиков, В. С., Игоревич, А. И., Belkin, A. A., et al. (2022) · Annals of critical care · doi:10.21320/1818-474x-2022-1-5-140 · Cited by 13
Risk and reward: extending stochastic glycaemic control intervals to reduce workload
Uyttendaele, V., Knopp, J. L., Shaw, G. M., Desaive, T., & Chase, J. G. (2020) · BioMedical Engineering OnLine · doi:10.1186/s12938-020-00771-6 · Cited by 12
The Long and Winding Road to Personalized Glycemic Control in the Intensive Care Unit
Tickoo, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1697603 · Cited by 11
Acute and Chronic Glucose Control in Critically Ill Patients With Diabetes: The Impact of Prior Insulin Treatment
Krinsley, J. S., Rule, P., Brownlee, M., Roberts, G., Preiser, J., Chaudry, S., Dionne, K., Heluey-Rodrigues, C., Umpierrez, G. E., & Hirsch, I. B. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211032277 · Cited by 11
Self-citation
Proportion of time spent in blood glucose range 70 to 140 mg/dL is associated with increased survival in patients admitted to ICU after cardiac arrest
Zhou, D., Li, Z., Shi, G.-Z., & Zhou, J. (2020) · Medicine · doi:10.1097/md.0000000000021728 · Cited by 11
Comparison of the efficacy and safety of insulin degludec/aspart (twice-daily injections), insulin glargine 300 u/ml, and insulin glulisine (basal-bolus therapy)
Kawaguchi, Y., Sawa, J., Hamai, C., Nishimura, Y., & Kumeda, Y. (2019) · Journal of Diabetes Investigation · doi:10.1111/jdi.13038 · Cited by 10
Admission Blood Glucose Is Associated With the 30-Days Mortality in Septic Patients: A Retrospective Cohort Study
Wei, X., Min, Y., Yu, J.-C., Wang, Q., Wang, H., Li, S., & Su, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.757061 · Cited by 10
Nurse-Directed Blood Glucose Management in a Medical Intensive Care Unit
Compton, F., Ahlborn, R., & Weidehoff, T. (2017) · Critical Care Nurse · doi:10.4037/ccn2017922 · Cited by 10
Performance of a closed-loop glucose control system, comprising a continuous glucose monitoring system and an AI-based controller in swine during severe hypo- and hyperglycemic provocations
DeJournett, J., Nekludov, M., DeJournett, L., & Wallin, M. K. E. B. (2020) · Journal of Clinical Monitoring and Computing · doi:10.1007/s10877-020-00474-2 · Cited by 10
Continuous versus intermittent feeding of the critically ill: have we made progress?
Pletschette, Z., & Preiser, J. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000733 · Cited by 10
Self-citation
Estimating Enhanced Endogenous Glucose Production in Intensive Care Unit Patients with Severe Insulin Resistance
Anane, Y., Szlávecz, Á., Knopp, J. L., Razak, N. N. A., Abu-Samah, A., Shaw, G. M., Chase, J. G., & Benyó, B. I. (2021) · Journal of Diabetes Science and Technology · doi:10.1177/19322968211018260 · Cited by 10
Mechanisms of early glucose regulation disturbance after out-of-hospital cardiopulmonary resuscitation: An explorative prospective study
Vihonen, H., Kuisma, M., Salo, A., Ångerman, S., Pietiläinen, K. H., & Nurmi, J. O. (2019) · PLoS ONE · doi:10.1371/journal.pone.0214209 · Cited by 10
Is It Time to Rethink Blood Glucose Targets in Critically Ill Patients?
Krinsley, J. S. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.05.010 · Cited by 10
Self-citation
Hypoglycemia Reduction Strategies in the ICU
Braithwaite, S. S., Bavda, D. B., Idrees, T., Qureshi, F. M., & Soetan, O. T. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0963-3 · Cited by 10
Relationship Between Glucose Time in Range in Diabetic and Non-Diabetic Patients and Mortality in Critically Ill Patients
Ammar, M. A., Ammar, A. A., Wee, T., Deshpande, R. P., Band, M., & Akhtar, S. (2022) · Journal of Intensive Care Medicine · doi:10.1177/08850666221098383 · Cited by 9
Greater low-density lipoprotein cholesterol variability is associated with increased progression to dialysis in patients with chronic kidney disease stage 3
Lin, Y., Huang, J., Wu, P.-Y., Chen, S., Chiu, Y., Chang, J., & Chen, H. (2017) · Oncotarget · doi:10.18632/oncotarget.23228 · Cited by 9
The practice of glycaemic control in intensive care units: A multicentre survey of nursing and medical professionals
Fernández‐Méndez, R., Harvey, D., Windle, R. J., & Adams, G. G. (2019) · Journal of Clinical Nursing · doi:10.1111/jocn.14774 · Cited by 9
Time in range is a tool for assessing the quality of glycemic control in diabetes
Суплотова, Л. А., Сергеевна, С. А., Романова, Н. В., & Shestakova, M. V. (2021) · Diabetes Mellitus · doi:10.14341/dm12703 · Cited by 9
Dysglycemias in patients admitted to ICUs with severe acute respiratory syndrome due to COVID-19 versus other causes - a cohort study
Rea, R. R., Bernardelli, R. S., Kozesinski-Nakatani, A. C., Olandoski, M., Martins-Junior, M. J., de Oliveira, M. C., & Réa-Neto, Á. (2023) · BMC Pulmonary Medicine · doi:10.1186/s12890-023-02439-y · Cited by 9
Association between time in range of relative normoglycemia and in-hospital mortality in critically ill patients: a single-center retrospective study
Okazaki, T., Inoue, A., Taira, T., Nakagawa, S., Kawakita, K., & Kuroda, Y. (2022) · Scientific Reports · doi:10.1038/s41598-022-15795-2 · Cited by 8
Association of the time in targeted blood glucose range of 3.9–10 mmol/L with the mortality of critically ill patients with or without diabetes
Yu, G., Ma, H., Lv, W., Zhou, P., & Liu, C. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e13662 · Cited by 8
Postoperative Glycemic Variability and Adverse Outcomes After Posterior Cervical Fusion
Patel, P. D., Canseco, J. A., Wilt, Z. T., Okroj, K. T., Chang, M. P., Reyes, A. A., Bowles, D. R., Kurd, M. F., Rihn, J. A., Anderson, D. G., et al. (2020) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-20-00126 · Cited by 8
The state of variability: A vision for descriptors of glycaemia
Zhou, T., Knopp, J. L., & Chase, J. G. (2019) · Annual Reviews in Control · doi:10.1016/j.arcontrol.2019.06.004 · Cited by 8
Association between time in range 70-180 mg/dl in early stage and severity with in patients acute pancreatitis
Meng, C., Zhang, J., Wang, Y., Ye, X., & Zhuang, S. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01414-2 · Cited by 7
Improving glycemic control: transitioning from dulaglutide to tirzepatide in patients with type 2 diabetes undergoing hemodialysis
Otsuka, E., Kitamura, M., Funakoshi, S., Mukae, H., & Nishino, T. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1362242 · Cited by 7
Comparative Simulation Study of Glucose Control Methods Designed for Use in the Intensive Care Unit Setting via a Novel Controller Scoring Metric
DeJournett, J., & DeJournett, L. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817711297 · Cited by 7

Authors: Krinsley, J. S., & Preiser, J.-C.
Affiliations: Stamford Hospital (US)
Université Libre de Bruxelles (BE)
Corresponding author: Krinsley, James S
ORCID: Krinsley, James S
Preiser, Jean-Charles
Venue: Critical Care
Publisher: Springer Science and Business Media LLC
Published: 2015-12
Volume: 19
Issue: 1
Pages: 179-179
ISSN: 1364-8535 (ISSN-L)
DOI: 10.1186/s13054-015-0908-7
PMC: PMC4446958
OpenAlex: W2072148089
Cited by: 174
References: 41
Citations by year: 2026: 15 · 2025: 10 · 2024: 12 · 2023: 9 · 2022: 13 · 2021: 15 · 2020: 23 · 2019: 25 · 2018: 15 · 2017: 21 · 2016: 10 · 2015: 6
FWCI: 15.07
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Critical Care (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Keywords: time in range, blood glucose, critically ill adults, mortality, intensive care unit, diabetes mellitus, non-diabetic patients, hypoglycemia, hyperglycemia, glycemic variability, intensive insulin therapy, disease severity, ICU length of stay, mortality risk factors, intensive care unit admission criteria
MeSH terms: Aged, Aged, 80 and over, Blood Chemical Analysis, Blood Glucose, Diabetes Mellitus, Female, Humans, Male, Middle Aged, Prospective Studies, Retrospective Studies, Time Factors, Cohort Studies, Survival Rate, Critical Illness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Time in blood glucose range 70 to 140 mg/dl >80% is strongly associated with increased survival in non-diabetic critically ill adults

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks